13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of type 2 diabetes mellitus and its predictive factors in Italy: a comparison between HIV-infected and uninfected subjects

      abstract
      1 , , 1 , 2 , 3 , 4 , 1 , 1 , 1 , 1 , 1 , 1
      Journal of the International AIDS Society
      BioMed Central
      Tenth International Congress on Drug Therapy in HIV Infection
      7-11 November 2010

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose of the study We determined the prevalence of type-2 diabetes mellitus (DM) in HIV infected (HIV+) and uninfected (HIV-) subjects. Methods Cross-sectional analysis on HIV+ patients (pts), aged >18 years [median(IQR): 46(41-51)], who attended the Infectious Diseases Department of the San Raffaele Scientific Institute, alive or lost or dead after 2007 and HIV- subjects, healthy workers, aged >18 years [median(IQR): 47(40-53)], evaluated between 2007-2008, all over Italy (15 Italian regions), in a campaign for the assessment of cardiovascular risk factors, promoted by the Occupational Medicine of the H San Raffaele Resnati. Logistic regression used to determine the risk of DM; odds ratios(OR) and its 95% confidence intervals reported. Results 4249 HIV+ (3248 males) and 9148 HIV- (7052 males) individuals. HIV+ pts had a higher prevalence of DM than HIV- [N=172 (4.1%) vs N=225 (2.5%), p<0.0001; OR=1.68 (1.37-2.05)]. Prevalence of DM was still higher among HIV+ than HIV- after controlling for body mass index (BMI) [<25: 3.2% vs 1.1%; 25-29.9: 2.9% vs 3.1%; >=30: 12.7% vs 7.8%; OR=1.79(1.29-2.50)], age [<=50 years old (yrs): 1.7% vs 1.2%; >50yrs: 10.8% vs 4.9%; OR=2.02(1.65-2.49)] or gender [Females: 2.7% vs 1.1%; Males: 4.5% vs 2.9%; OR=1.69(1.38-2.06)] or both factors [Females<=50yrs: 0.9% vs 0.8%; Females >50yrs: 11.1% vs 1.8%; Males<=50yrs: 2.0% vs 1.3%; Males>50yrs: 10.8% vs 5.6%; OR=2.02(1.64-2.48)]. Among subjects with DM, HIV+ pts were significantly different compared to HIV- as follows: were older(p<0.0001), had a lower BMI(p<0.0001), lower cholesterol(p<0.0001), lower HDL-cholesterol(p<0.0001), lower fasting glucose(p<0.0001) and higher triglycerides (p=0.019). HIV+ and HIV- pts with DM were similar with respect to LDL-cholesterol, systolic and diastolic pressure and smoking status. After adjustment for age (<=50yrs, >50yrs), gender, BMI (<25, 25-29.9, >=30), cholesterol, HDL- and LDL-cholesterol, triglycerides and hypertension (yes vs no), HIV+ pts had a higher risk of diabetes (OR=1.71(1.02-2.86), p=0.043). Increasing age [>50yrs vs <=50yrs: OR=4.10(3.01-5.59), p<0.0001] or BMI [25-29.9 vs <25: OR=1.87(1.28-2.74); >=30 vs <25: OR=4.67(3.08-7.10); overall effect: p<0.0001] were also predictive factors of a greater risk of DM. Conclusions Our findings suggest an increased prevalence of type-2 diabetes in HIV+ than HIV- subjects which was almost doubled in HIV+ than HIV- and up to 4-fold higher among obese subjects or those aged>50 years.

          Related collections

          Author and article information

          Conference
          J Int AIDS Soc
          Journal of the International AIDS Society
          BioMed Central
          1758-2652
          2010
          8 November 2010
          : 13
          : Suppl 4
          : P230
          Affiliations
          [1 ]San Raffaele Scientific Institute, Infectious Diseases, Milan, Italy
          [2 ]San Raffaele Scientific Institute, Occupational Health, Milan, Italy
          [3 ]H San Raffaele Resnati, Milan, Italy
          [4 ]San Raffaele Scientific Institute, Internal Medicine Department, Milan, Italy
          Article
          1758-2652-13-S4-P230
          10.1186/1758-2652-13-S4-P230
          3113017
          8726f380-1ea5-4a98-9a8b-93d0749ca613
          Copyright ©2010 Galli et al; licensee BioMed Central Ltd.

          This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

          Tenth International Congress on Drug Therapy in HIV Infection
          Glasgow, UK
          7-11 November 2010
          History
          Categories
          Poster Presentation

          Infectious disease & Microbiology
          Infectious disease & Microbiology

          Comments

          Comment on this article